Erosive pustular dermatosis of the scalp secondary to Erlotinib: A rare occurrence with trichoscopic perspective.

IF 1.1 Q2 MEDICINE, GENERAL & INTERNAL

Journal of the Royal College of Physicians of Edinburgh Pub Date : 2023-12-01 Epub Date: 2023-08-30 DOI:10.1177/14782715231196606

Sharang Gupta, Dimple Chopra, Preeyati

引用次数: 0

Abstract

Epidermal growth factor receptor inhibitors are anti-tumour agents that are frequently used for the treatment of neoplastic disorders. In addition to their cutaneous adverse effects, these drugs can rarely lead to erosive pustular dermatosis of the scalp. We report a case of a 67-year-old female who developed erosive pustular dermatosis of the scalp after being started on erlotinib from a trichoscopic perspective, which has been described in literature only once till now.

查看原文本刊更多论文

继发于厄洛替尼的头皮侵蚀性脓疱性皮肤病：罕见病例与三镜透视。

表皮生长因子受体抑制剂是一种抗肿瘤药物，常用于治疗肿瘤性疾病。除了皮肤不良反应外，这类药物在极少数情况下还会导致头皮糜烂性脓疱性皮肤病。我们报告了一例 67 岁女性的病例，她在开始服用厄洛替尼后出现了头皮糜烂性脓疱性皮肤病。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of the Royal College of Physicians of Edinburgh MEDICINE, GENERAL & INTERNAL-

CiteScore

1.80

自引率

0.00%

发文量

审稿时长

20 weeks

期刊介绍： The Journal of the Royal College of Physicians of Edinburgh (JRCPE) is the College’s quarterly, peer-reviewed journal, with an international circulation of 8,000. It has three main emphases – clinical medicine, education and medical history. The online JRCPE provides full access to the contents of the print journal and has a number of additional features including advance online publication of recently accepted papers, an online archive, online-only papers, online symposia abstracts, and a series of topic-specific supplements, primarily based on the College’s consensus conferences.